Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University
5
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Community-based Post-exposure Prophylaxis for COVID-19
Role: collaborator
Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research
Role: collaborator
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
Role: collaborator
Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
Role: collaborator
Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown
Role: collaborator
All 5 trials loaded